Pevonedistat in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis
Clinical trial NCT03386214 · TERMINATED
Trial details
- NCT number
- NCT03386214
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-23
- Primary completion
- 2021-09-12
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.